NCT06806488View on ClinicalTrials.gov

Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas

RecruitingOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Marginal Zone B Cell Lymphoma
Trial Locations (1)

40138

RECRUITING

IRCCS Azienda Ospedaliero - Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT06806488 - Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas | Biotech Hunter | Biotech Hunter